ukmla MCQ (SBA): HFrEF therapy – SGLT2

Instant feedback + full explanation. One question, done properly.

MediumCardiologyHFrEF therapy – SGLT2ukmlamrcp part 1mrcgp aktpane

A 72-year-old man with HFrEF is euvolaemic on ACEi, beta-blocker, and MRA. HR 78 bpm sinus rhythm; BP 124/70. Which additional class reduces mortality further?

Practice more on iatroX

Educational content. Not a substitute for clinical judgement or local policy.